Nafcillin
Back to searchMolecule Structure
Scientific Name
Nafcillin
Description of the Drug
Nafcillin is a penicillin derivative antibiotic used to treat susceptible staphylococcal infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00607
http://www.drugbank.ca/drugs/DB00607
Brand Name(s)
Not Available
Company Owner(s)
Wytells Pharma Private Ltd, Wyeth Ayerst Laboratories, Steriscience Pte Ltd, Glaxosmithkline, Apothecon Inc Div Bristol Myers Squibb, Sagent Pharmaceuticals Inc, Sandoz Inc, Istituto Biochimico Italiano Spa, Watson Laboratories Inc, Fresenius Kabi Ipsum Srl
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2362972 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL47797 | ||
PharmGKB | PA450576 | ||
Human Metabolome Database | HMDB0014745 | ||
DrugBank | DB00607 | ||
PubChem: Thomson Pharma | 14929045 | ||
PubChem | 8982 | ||
LINCS | LSM-2402 | ||
Nikkaji | J10.134F | ||
BindingDB | 50103525 | ||
EPA CompTox Dashboard | DTXSID8023343 | ||
DrugCentral | 1869 | ||
ChemicalBook | CB9914919 | ||
Guide to Pharmacology | 10942 | ||
rxnorm | NAFCILLIN SODIUM | NAFCILLIN | NAFCILLIN SODIUM MONOHYDRATE |
KEGG Ligand | C07250 | ||
ChEBI | 7447 | ||
ZINC | ZINC000003875980 |